Notably, CDC37 overexpression is a hallmark of cancer, and its recruitment to the HSP90 complex promotes oncogenesis, making the disruption of HSP90–CDC37–kinase interactions a potential target for cancer therapies46. Here, CDC37 is linked to cancer.